These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10359140)

  • 21. Supratentorial gliomas: a comparative study by grade and histologic type.
    Shaw EG; Scheithauer BW; O'Fallon JR
    J Neurooncol; 1997 Feb; 31(3):273-8. PubMed ID: 9049856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.
    Costello JF; Berger MS; Huang HS; Cavenee WK
    Cancer Res; 1996 May; 56(10):2405-10. PubMed ID: 8625319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index.
    Bouvier-Labit C; Civatte M; Bartoli C; Renaud W; Pellissier JF; Figarella-Branger D
    Neuropathol Appl Neurobiol; 1999 Oct; 25(5):408-16. PubMed ID: 10564531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Karyotypes in 90 human gliomas.
    Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
    Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
    Smith JS; Perry A; Borell TJ; Lee HK; O'Fallon J; Hosek SM; Kimmel D; Yates A; Burger PC; Scheithauer BW; Jenkins RB
    J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.
    Ranuncolo SM; Varela M; Morandi A; Lastiri J; Christiansen S; Bal de Kier Joffé E; Pallotta MG; Puricelli L
    J Neurooncol; 2004 Jun; 68(2):113-21. PubMed ID: 15218947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
    Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.
    Richardson TE; Sathe AA; Xing C; Mirchia K; Viapiano MS; Snuderl M; Abdullah KG; Hatanpaa KJ; Walker JM
    J Neuropathol Exp Neurol; 2021 Mar; 80(4):354-365. PubMed ID: 33755138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
    Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
    Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
    Ransom DT; Ritland SR; Kimmel DW; Moertel CA; Dahl RJ; Scheithauer BW; Kelly PJ; Jenkins RB
    Genes Chromosomes Cancer; 1992 Nov; 5(4):348-56. PubMed ID: 1283324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H
    Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlative immunohistochemistry and molecular genetic study of the inactivation of the p16INK4A genes in astrocytomas.
    Rao LS; Miller DC; Newcomb EW
    Diagn Mol Pathol; 1997 Apr; 6(2):115-22. PubMed ID: 9098651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling and subgroup identification of oligodendrogliomas.
    Huang H; Okamoto Y; Yokoo H; Heppner FL; Vital A; Fevre-Montange M; Jouvet A; Yonekawa Y; Lazaridis EN; Kleihues P; Ohgaki H
    Oncogene; 2004 Aug; 23(35):6012-22. PubMed ID: 15208679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of 14q chromosome in oligodendroglial and astrocytic tumors.
    Dichamp C; Taillibert S; Aguirre-Cruz L; Lejeune J; Marie Y; Kujas M; Delattre JY; Hoang-Xuan K; Sanson M
    J Neurooncol; 2004 May; 67(3):281-5. PubMed ID: 15164983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supratentorial recurrences of gliomas. Results of reoperations on astrocytomas and oligodendrogliomas.
    Afra D; Müller W; Benoist G; Schröder R
    Acta Neurochir (Wien); 1978; 43(3-4):217-27. PubMed ID: 707178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.
    Sturm I; Petrowsky H; Volz R; Lorenz M; Radetzki S; Hillebrand T; Wolff G; Hauptmann S; Dörken B; Daniel PT
    J Clin Oncol; 2001 Apr; 19(8):2272-81. PubMed ID: 11304781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas.
    Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Saito T; Matsuura S; Yamasaki F; Arita K; Kurisu K
    J Neurooncol; 2006 May; 77(3):273-7. PubMed ID: 16614947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.